Backed by $123 million in venture investments, Christina Smolke’s company Anthiea just completed its first scaled production of a key drug ingredient.
This Scientist-Entrepreneur Is Brewing Prescription Drug Ingredients Like They Were Beer
Backed by $123 million in venture investments, Christina Smolke’s company Anthiea just completed its first scaled production of a key drug ingredient.